PDEX - Pro-Dex Inc Stock Price, Fair Value and News

19.50USD-0.45 (-2.26%)Delayed

Market Summary

USD19.50-0.45

Delayed

-2.26%

PDEX Stock Price

View Fullscreen

PDEX RSI Chart

PDEX Valuation

Market Cap

66.7M

Price/Earnings (Trailing)

20.87

Price/Sales (Trailing)

1.35

EV/EBITDA

10.61

Price/Free Cashflow

13.9

PDEX Price/Sales (Trailing)

PDEX Profitability

Operating Margin

27.94%

EBT Margin

8.71%

Return on Equity

10.32%

Return on Assets

6.32%

Free Cashflow Yield

7.19%

PDEX Fundamentals

PDEX Revenue

Revenue (TTM)

49.5M

Rev. Growth (Yr)

9.28%

Rev. Growth (Qtr)

13.54%

PDEX Earnings

Earnings (TTM)

3.2M

Earnings Growth (Yr)

-59.49%

Earnings Growth (Qtr)

31%

Breaking Down PDEX Revenue

Last 7 days

4.8%

Last 30 days

6.8%

Last 90 days

10.4%

Trailing 12 Months

17.5%

How does PDEX drawdown profile look like?

PDEX Financial Health

Current Ratio

3.45

Debt/Equity

0.34

Debt/Cashflow

0.55

PDEX Investor Care

Buy Backs (1Y)

99.90%

Diluted EPS (TTM)

0.9

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	49.5M	0	0	0
2023	45.1M	46.1M	46.9M	48.2M
2022	41.7M	42.0M	43.1M	44.1M
2021	39.7M	38.0M	39.4M	41.3M
2020	30.7M	34.8M	36.2M	36.5M
2019	26.4M	27.2M	27.5M	29.1M
2018	21.8M	22.5M	24.2M	25.1M
2017	21.3M	21.9M	22.0M	22.9M
2016	18.6M	19.3M	19.9M	20.6M
2015	12.5M	13.4M	14.9M	17.3M
2014	10.3M	10.8M	10.9M	11.0M
2013	13.2M	12.2M	11.3M	11.0M
2012	19.6M	17.3M	15.7M	14.7M
2011	0	24.8M	24.1M	21.9M
2010	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Pro-Dex Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jan 25, 2024	domingo angelita rebamontan	acquired	641	18.32	35.00	-
Jul 27, 2023	domingo angelita rebamontan	acquired	648	15.82	41.00	-
Jul 27, 2023	van kirk richard lee jr	acquired	7,799	15.82	493	chief executive officer
Jan 26, 2023	domingo angelita rebamontan	acquired	635	14.79	43.00	-
Jan 26, 2023	van kirk richard lee jr	acquired	7,794	14.79	527	chief executive officer
Dec 08, 2022	hovda david	acquired	3,210	2.14	1,500	-
Aug 30, 2022	van kirk richard lee jr	acquired	8,650	1.73	5,000	chief executive officer
Jul 28, 2022	van kirk richard lee jr	acquired	7,801	13.52	577	chief executive officer
Jul 28, 2022	domingo angelita rebamontan	acquired	405	13.52	30.00	-
Jul 14, 2022	domingo angelita rebamontan	acquired	-	-	5,800	-

Which funds bought or sold PDEX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	STATE STREET CORP	reduced	-13.09	-26,002	186,434	-%
May 15, 2024	MORGAN STANLEY	added	15.61	42,564	306,240	-%
May 15, 2024	BANK OF AMERICA CORP /DE/	sold off	-100	-18.00	-	-%
May 15, 2024	Tower Research Capital LLC (TRC)	added	99.77	7,603	15,154	-%
May 15, 2024	Covalent Partners LLC	reduced	-10.22	-26,908	247,333	1.89%
May 15, 2024	PERRITT CAPITAL MANAGEMENT INC	added	43.3	32,244	105,600	0.06%
May 15, 2024	PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.	added	2.9	43,270	1,328,800	0.08%
May 15, 2024	Royal Bank of Canada	reduced	-42.19	-	1,000	-%
May 14, 2024	NORTHERN TRUST CORP	reduced	-3.14	-12,219	441,549	-%
May 14, 2024	NewEdge Advisors, LLC	unchanged	-	-	18.00	-%

Are Funds Buying or Selling PDEX?

Are funds buying PDEX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own PDEX

No. of Funds

Unveiling Pro-Dex Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 22, 2021	swenson nicholas john	24.0%	927,177	SC 13D/A
Nov 25, 2020	farnam street partners lp /mn	9.4%	360,846	SC 13D/A

Recent SEC filings of Pro-Dex Inc

View All Filings

Date Filed	Form Type	Document
May 02, 2024	8-K	Current Report
May 02, 2024	10-Q	Quarterly Report
Feb 08, 2024	8-K	Current Report
Feb 08, 2024	10-Q	Quarterly Report

Peers (Alternatives to Pro-Dex Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.13%	32.26%	-0.09	0.28	5.77%	8.23%

Pro-Dex Inc News

Latest updates

Stock Traders Daily • 13 May 2024 • 10:54 am

(PDEX) Proactive Strategies

MarketBeat • 12 May 2024 • 10:10 pm

Pro-Dex, Inc. (NASDAQ:PDEX) Short Interest Update

Stock Traders Daily • 03 May 2024 • 04:24 pm

(PDEX) Investment Analysis and Advice

Investing.com South Africa • 02 May 2024 • 07:00 am

Pro-Dex, Inc. Announces Fiscal 2024 Third Quarter And Nine-Month Results

Stock Traders Daily • 23 Apr 2024 • 10:36 pm

(PDEX) Technical Pivots with Risk Controls

InvestorPlace • 5 months ago

3 Very Undervalued Stocks With Strong Growth Prospects

Stock Day Media • 6 months ago

October 2023 – Stock Day Media

Yahoo Lifestyle Australia • 2 years ago

Great news for Pro-Dex, Inc. (NASDAQ:PDEX): Insiders acquired stock in large numbers last year

Stock Day Media • 4 years ago

News – Stock Day Media

FEI Daily • 5 years ago

Event Speaker Bio

Pro-Dex Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	13.5%	14,293	12,588	11,938	10,639	13,079	11,282	11,087	10,782	10,478	10,173	9,988	9,435	11,739	8,265	8,590	11,125	8,508	7,961	7,240	7,004	6,854
Cost Of Revenue	5.2%	10,291	9,786	8,280	7,280	9,268	8,659	8,131	9,173	6,407	6,769	6,560	6,316	7,354	5,669	5,115	6,837	5,298	5,097	4,460	4,462	4,591
Gross Profit	42.8%	4,002	2,802	3,658	3,359	3,811	2,623	2,956	3,443	2,858	3,404	3,428	3,119	4,385	2,596	3,475	4,288	3,210	2,864	2,780	2,542	2,263
Operating Expenses	-11.7%	1,789	2,025	1,825	1,749	1,746	1,486	2,006	2,260	1,837	1,802	2,110	2,529	2,520	2,075	1,926	2,085	1,506	1,196	1,289	1,362	1,366
S&GA Expenses	-54.1%	17.00	37.00	25.00	10.00	24.00	68.00	53.00	12.00	20.00	22.00	37.00	175	136	150	130	139	161	135	142	163	122
R&D Expenses	-3.6%	760	788	805	695	713	467	929	727	658	615	980	1,200	1,104	989	1,091	814	620	397	484	545	603
EBITDA Margin	-18.7%	0.12*	0.15*	0.22*	0.27*	0.24*	0.22*	0.17*	0.17*	0.17*	0.22*	0.24*	0.25*	0.26*	0.25*	0.24*	0.25*	0.22*	-	-	-	-
Interest Expenses	-0.7%	138	139	133	144	131	128	130	115	112	117	120	121	102	75.00	54.00	56.00	58.00	63.00	59.00	64.00	67.00
Income Taxes	115.0%	258	120	-214	950	570	1,004	266	304	215	344	313	437	604	143	267	596	442	389	363	281	191
Earnings Before Taxes	47.3%	913	620	-829	3,604	2,187	3,756	1,469	2,283	789	1,426	1,393	2,277	2,765	1,930	1,382	3,142	1,655	1,638	1,467	1,169	923
EBT Margin	-24.7%	0.09*	0.12*	0.19*	0.24*	0.22*	0.19*	0.14*	0.14*	0.14*	0.19*	0.21*	0.22*	0.23*	0.22*	0.22*	0.23*	0.19*	-	-	-	-
Net Income	31.0%	655	500	-615	2,654	1,617	2,752	1,203	1,837	574	1,082	1,080	1,107	2,161	1,787	1,115	2,546	1,213	1,249	1,104	888	732
Net Income Margin	-25.0%	0.06*	0.09*	0.14*	0.18*	0.16*	0.14*	0.11*	0.11*	0.09*	0.13*	0.16*	0.16*	0.19*	0.18*	0.17*	0.18*	0.15*	-	-	-	-
Free Cashflow	5042.9%	3,960	77.00	266	492	2,203	-904	2,714	-5,647	15.00	1,294	1,853	-639	-3,977	1,884	-977	2,586	-321	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-1.7%	51.00	51.00	50.00	52.00	52.00	52.00	50.00	49.00	45.00	43.00	43.00	40.00	43.00	39.00	31.00	31.00	28.00	29.00	28.00	26.00	26.00
Current Assets	-1.8%	36.00	37.00	31.00	31.00	31.00	31.00	32.00	31.00	28.00	26.00	26.00	25.00	27.00	23.00	23.00	23.00	21.00	21.00	20.00	21.00	22.00
Cash Equivalents	149.7%	3.00	1.00	1.00	3.00	2.00	0.00	3.00	1.00	5.00	5.00	5.00	4.00	4.00	6.00	5.00	6.00	4.00	6.00	7.00	8.00	10.00
Inventory	-5.2%	14.00	15.00	16.00	16.00	15.00	15.00	16.00	13.00	12.00	9.00	9.00	8.00	8.00	9.00	8.00	8.00	9.00	8.00	7.00	6.00	5.00
Net PPE	-2.6%	5.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00	-	-	-	4.00	-	-	3.00	3.00	3.00	3.00	3.00	3.00	3.00
Liabilities	-0.2%	20.00	20.00	18.00	20.00	22.00	24.00	24.00	24.00	22.00	20.00	20.00	20.00	22.00	17.00	11.00	12.00	11.00	11.00	11.00	3.00	8.00
Current Liabilities	4.3%	10.00	10.00	8.00	10.00	10.00	12.00	12.00	11.00	8.00	6.00	6.00	6.00	6.00	5.00	4.00	5.00	4.00	4.00	4.00	4.00	4.00
Long Term Debt	-	-	-	-	-	-	-	-	-	11.00	11.00	11.00	12.00	12.00	8.00	3.00	3.00	3.00	4.00	4.00	4.00	4.00
Shareholder's Equity	-2.7%	31.00	32.00	7.00	32.00	26.00	28.00	19.00	8.00	22.00	14.00	13.00	21.00	20.00	13.00	13.00	19.00	17.00	18.00	17.00	17.00	18.00
Retained Earnings	2.7%	25.00	25.00	24.00	25.00	23.00	22.00	19.00	18.00	16.00	15.00	14.00	12.00	12.00	10.00	8.00	8.00	5.00	4.00	3.00	2.00	1.00
Accumulated Depreciation	-	-	-	-	8.00	-	-	-	8.00	-	-	-	8.00	-	-	-	7.00	-	-	-	7.00	-
Shares Outstanding	-2.5%	3.00	4.00	4.00	-	3,548	-	-	-	3,626	3,657	3,651	3,656	3,817	3,861	3,851	-	4.00	4.00	4.00	-	-
Float	-	-	-	-	-	-	33.00	-	-	-	50.00	-	-	-	75.00	-	-	-	42.00	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	474.2%	4,077	710	392	627	2,338	-395	2,892	-5,279	213	1,518	2,701	725	-3,888	1,973	-888	2,647	-260	1,650	908	241	1,577
Share Based Compensation	2.5%	202	197	189	182	206	171	207	343	357	275	300	393	444	38.00	26.00	193	74.00	7.00	12.00	9.00	10.00
Cashflow From Investing	93.8%	-117	-1,883	-126	-152	-135	-508	-90.00	401	-206	-556	-874	665	2,328	-6,728	25.00	-34.00	-642	-288	-1,323	-690	-525
Cashflow From Financing	-463.8%	-2,030	558	-1,298	373	-497	-1,513	-853	966	-498	-887	-371	-1,543	-89.00	5,076	-356	-570	-895	-1,689	-825	-1,470	-262
Buy Backs	1510.3%	1,723	107	-	-	198	995	354	351	584	577	95.00	1,498	4,039	8,500	-	411	761	1,535	681	1,309	115

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

PDEX Income Statement

2024-03-31

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 14,293	$ 13,079	$ 38,819	$ 35,448
Cost of sales	10,291	9,268	28,357	26,058
Gross profit	4,002	3,811	10,462	9,390
Operating expenses:
Selling expenses	17	24	79	146
General and administrative expenses	1,012	1,009	3,208	2,983
Research and development costs	760	713	2,353	2,109
Total operating expenses	1,789	1,746	5,640	5,238
Operating income	2,213	2,065	4,822	4,152
Interest expense	138	131	409	389
Unrealized gain (loss) on marketable equity investments	(1,192)	242	(3,785)	3,407
Interest and other income	30	11	76	235
Gain on sale of investments	0	0	0	7
Income before income taxes	913	2,187	704	7,412
Income tax expense	258	570	164	1,840
Net income	$ 655	$ 1,617	$ 540	$ 5,572
Basic net income per share:
Net income	$ 0.19	$ 0.46	$ 0.15	$ 1.56
Diluted net income per share:
Net income	$ 0.19	$ 0.45	$ 0.15	$ 1.52
Weighted average common shares outstanding:
Basic	3,451	3,548	3,531	3,580
Diluted	3,524	3,623	3,604	3,656
Common shares outstanding	3,451	3,545	3,451	3,545

PDEX Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Jun. 30, 2023
Current Assets:
Cash and cash equivalents	$ 3,219	$ 2,936
Investments	4,577	1,134
Accounts receivable, net of allowance for expected credit losses of $1 and $0 at March 31, 2024 and at June 30, 2023, respectively	12,516	9,952
Deferred costs	331	494
Inventory	14,242	16,167
Prepaid expenses and other current assets	1,072	296
Total current assets	35,957	30,979
Land and building, net	6,179	6,249
Equipment and leasehold improvements, net	5,191	5,079
Right of use asset, net	1,575	1,872
Intangibles, net	61	81
Investments	1,543	7,521
Other assets	42	42
Total assets	50,548	51,823
Current Liabilities:
Accounts payable	3,435	2,261
Accrued expenses	2,701	3,135
Deferred revenue	35	0
Income taxes payable	390	453
Note payable	3,858	3,827
Total current liabilities	10,419	9,676
Lease liability, net of current portion	1,299	1,638
Deferred income taxes, net	8	8
Notes payable, net of current portion	7,884	8,911
Total non-current liabilities	9,191	10,557
Total liabilities	19,610	20,233
Shareholders’ equity:
Common shares; no par value; 50,000,000 shares authorized; 3,451,423 and 3,545,309 shares issued and outstanding at March 31, 2024 and June 30, 2023, respectively	5,575	6,767
Retained earnings	25,363	24,823
Total shareholders’ equity	30,938	31,590
Total liabilities and shareholders’ equity	$ 50,548	$ 51,823

About Pro-Dex Inc

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

CEO	Mr. Richard Lee Van Kirk Jr.
WEBSITE	pro-dex.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	134

Pro-Dex Inc Frequently Asked Questions

What is the ticker symbol for Pro-Dex Inc? What does PDEX stand for in stocks?

PDEX is the stock ticker symbol of Pro-Dex Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Pro-Dex Inc (PDEX)?

As of Fri May 17 2024, market cap of Pro-Dex Inc is 66.67 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PDEX stock?

You can check PDEX's fair value in chart for subscribers.

What is the fair value of PDEX stock?

You can check PDEX's fair value in chart for subscribers. The fair value of Pro-Dex Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Pro-Dex Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PDEX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Pro-Dex Inc a good stock to buy?

The fair value guage provides a quick view whether PDEX is over valued or under valued. Whether Pro-Dex Inc is cheap or expensive depends on the assumptions which impact Pro-Dex Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PDEX.

What is Pro-Dex Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, PDEX's PE ratio (Price to Earnings) is 20.87 and Price to Sales (PS) ratio is 1.35. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PDEX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Pro-Dex Inc's stock?

In the past 10 years, Pro-Dex Inc has provided 0.248 (multiply by 100 for percentage) rate of return.